Jay Flatley

Executive Chairman, Illumina

BA in Economics, Claremont McKenna College; BSc and MSc (Hons) in Industrial Engineering, Stanford University. 1999-2016, Chief Executive Officer, Illumina; currently, Executive Chairman of the Board of Directors; during tenure as Chief Executive Officer, took the company from $1.3 million in sales in 2000 to $2.2 billion in 2015, representing a compound annual growth rate of 64%; oversaw the company’s expansion from microarrays into next-generation sequencing with the acquisition of Solexa in 2006, and from research into clinical and applied markets; led Illumina to be named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010), the Fortune 100 Fastest-Growing Companies (2010 and 2011) lists, and recognition by MIT Technology Review as the World’s Smartest Company in 2014. Chairman of the Board of Directors, Illumina and its subsidiary, Helix. Member of the Board of Directors: Coherent; Denali; Juno; Dodo Omnidata. Member of the Board of Trustees, The Salk Institute. Member of the Advisory Board, Moores Cancer Center, University of California, San Diego.